Attending Oncology Workshop Nov 2019 in Stockholm

November 2019

From mouse to man - Lessons learned, an oncology workshop

We are excited to invite you to a workshop that will be of great value for every stakeholder that has aspirations within cancer therapy development. GCP, GMP, GLP may rule our standard procedures. However, it is strategies, tactics and the management of the regulatory landscape as well as project execution, that will make your ideas successful. We are delighted to have such an experienced key panel present at our workshop. Together they have contributed to bringing more than 400 projects into the clinical phase and now they will share their precious findings with us.

Our key note speaker Dr Magnus Björsne, will provide us with insights into the changes in Big Pharma's strategy and lead a discussion on how that may influence the strategies of our drug development projects.

Welcome to contribute and share your thoughts with others!

When: Thursday, 21st November 14.00–17.15 and a following mingle.
Where: Konferens Spårvagnshallarna, Birger Jarlsgatan 57A, Stockholm.
RSVP: No later than November 15th, by clicking the link below.

The number of guests is limited.
No shows will be charged a fee of SEK 500.
Most presentations will be held in Swedish.

Agenda

Most presentations will be held in Swedish.

14.00 Welcome!
Moderator Viktor Backemar, Groth & Co

14.10 Preclinical chemistry development of oncology projects - from the CRO perspective.
Jonas Malmström, Recipharm

14.30 First in man preclinical package – the dynamics in preparations for successful study protocol
Dr Enrico Pesenti, Accelera

14.50 First in man clinical execution – 250 drugs in the clinic, take home message
Dr Jack Welch, Theradex Oncology

15.10 Fika

15.40 IP - Strategies to obtain exclusivity
Dr Malin Boström and Carl Wendt, Groth & Co

16.00 The art of naming pharmaceutical products
Olof Lindquist, Skriptor Zigila

16.20 Short break

16.25 What about if assumptions on industry expectations suddenly are wrong...
Dr Magnus Björsne, CEO, AstraZeneca BioVentureHub

16.55 Panel discussion

17.15 Mingle, buffet and drinks